Annual SGA
$8.14 M
-$7.52 M-48.04%
December 1, 2023
Summary
- As of March 10, 2025, ORMP annual SGA is $8.14 million, with the most recent change of -$7.52 million (-48.04%) on December 1, 2023.
- During the last 3 years, ORMP annual SGA has risen by +$6.56 million (+416.37%).
- ORMP annual SGA is now -48.04% below its all-time high of $15.66 million, reached on December 31, 2022.
Performance
ORMP SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly SGA
$847.00 K
-$846.00 K-49.97%
September 1, 2024
Summary
- As of March 10, 2025, ORMP quarterly SGA is $847.00 thousand, with the most recent change of -$846.00 thousand (-49.97%) on September 1, 2024.
- Over the past year, ORMP quarterly SGA has stayed the same.
- ORMP quarterly SGA is now -86.07% below its all-time high of $6.08 million, reached on March 31, 2022.
Performance
ORMP Quarterly SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM SGA
-$626.81 M
+$4.46 M+0.71%
September 1, 2024
Summary
- As of March 10, 2025, ORMP TTM SGA is -$626.81 million, with the most recent change of +$4.46 million (+0.71%) on September 1, 2024.
- Over the past year, ORMP TTM SGA has dropped by -$633.25 million (-9842.17%).
- ORMP TTM SGA is now -75057.19% below its all-time high of -$834.00 thousand.
Performance
ORMP TTM SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Selling, General & Administrative Expenses Formula
SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development
ORMP Selling, General & Administrative Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -48.0% | 0.0% | -9842.2% |
| 3 y3 years | +416.4% | 0.0% | -9842.2% |
| 5 y5 years | +118.7% | 0.0% | -9842.2% |
ORMP Selling, General & Administrative Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -48.0% | +94.1% | -86.1% | at low | -39.8% | +6.2% |
| 5 y | 5-year | -48.0% | +416.4% | -86.1% | +16.5% | -89.4% | +6.2% |
| alltime | all time | -48.0% | >+9999.0% | -86.1% | >+9999.0% | <-9999.0% | +6.2% |
Oramed Pharmaceuticals Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $847.00 K(-50.0%) | $6.43 M(-14.5%) |
| Jun 2024 | - | $1.69 M(-5.0%) | $7.52 M(-11.2%) |
| Mar 2024 | - | $1.78 M(-15.5%) | $8.47 M(+4.1%) |
| Dec 2023 | $8.14 M(-48.0%) | $2.11 M(+9.0%) | $8.14 M(-11.3%) |
| Sep 2023 | - | $1.94 M(-26.8%) | $9.17 M(-14.8%) |
| Jun 2023 | - | $2.64 M(+82.7%) | $10.76 M(-2.4%) |
| Mar 2023 | - | $1.45 M(-54.0%) | $11.03 M(-29.6%) |
| Dec 2022 | $15.66 M(+273.5%) | $3.14 M(-10.8%) | $15.66 M(+5.5%) |
| Sep 2022 | - | $3.52 M(+21.0%) | $14.84 M(+9.4%) |
| Jun 2022 | - | $2.91 M(-52.1%) | $13.57 M(+13.5%) |
| Mar 2022 | - | $6.08 M(+161.7%) | $11.95 M(+58.6%) |
| Dec 2021 | $4.19 M(-29.4%) | - | - |
| Nov 2021 | - | $2.32 M(+3.3%) | $7.53 M(+26.9%) |
| Aug 2021 | $5.94 M(+276.7%) | $2.25 M(+73.4%) | $5.94 M(+34.4%) |
| May 2021 | - | $1.30 M(-22.1%) | $4.42 M(+6.4%) |
| Feb 2021 | - | $1.66 M(+128.9%) | $4.15 M(+7.0%) |
| Dec 2020 | $1.58 M(-62.8%) | - | - |
| Nov 2020 | - | $727.00 K(-0.4%) | $3.88 M(-8.4%) |
| Aug 2020 | $4.23 M(+13.7%) | $730.00 K(-29.1%) | $4.23 M(-2.2%) |
| May 2020 | - | $1.03 M(-26.0%) | $4.33 M(+3.1%) |
| Feb 2020 | - | $1.39 M(+28.7%) | $4.20 M(+8.4%) |
| Nov 2019 | - | $1.08 M(+30.9%) | $3.87 M(+4.0%) |
| Aug 2019 | $3.72 M(-8.8%) | $826.00 K(-8.1%) | $3.72 M(-5.3%) |
| May 2019 | - | $899.00 K(-15.6%) | $3.93 M(-3.5%) |
| Feb 2019 | - | $1.06 M(+14.3%) | $4.07 M(+1.9%) |
| Nov 2018 | - | $932.00 K(-9.8%) | $4.00 M(-2.1%) |
| Aug 2018 | $4.08 M(+48.0%) | $1.03 M(-1.0%) | $4.08 M(+2.5%) |
| May 2018 | - | $1.04 M(+5.2%) | $3.98 M(+15.6%) |
| Feb 2018 | - | $991.00 K(-2.5%) | $3.45 M(+4.2%) |
| Nov 2017 | - | $1.02 M(+8.7%) | $3.31 M(+19.9%) |
| Aug 2017 | $2.76 M(+12.5%) | $935.00 K(+85.1%) | $2.76 M(+12.9%) |
| May 2017 | - | $505.00 K(-40.7%) | $2.44 M(-2.0%) |
| Feb 2017 | - | $851.00 K(+81.8%) | $2.49 M(+5.1%) |
| Nov 2016 | - | $468.00 K(-24.4%) | $2.37 M(-3.3%) |
| Aug 2016 | $2.45 M(-5.8%) | $619.00 K(+11.5%) | $2.45 M(-4.9%) |
| May 2016 | - | $555.00 K(-24.0%) | $2.58 M(-6.0%) |
| Feb 2016 | - | $730.00 K(+33.2%) | $2.74 M(+7.5%) |
| Nov 2015 | - | $548.00 K(-26.4%) | $2.55 M(-2.0%) |
| Aug 2015 | $2.60 M | $745.00 K(+3.6%) | $2.60 M(-5.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| May 2015 | - | $719.00 K(+33.6%) | $2.74 M(-3.3%) |
| Feb 2015 | - | $538.00 K(-10.3%) | $2.84 M(+0.9%) |
| Nov 2014 | - | $600.00 K(-32.2%) | $2.81 M(+6.9%) |
| Aug 2014 | $2.63 M(+29.4%) | $885.00 K(+8.7%) | $2.63 M(+8.3%) |
| May 2014 | - | $814.00 K(+59.0%) | $2.43 M(+14.9%) |
| Feb 2014 | - | $512.00 K(+22.5%) | $2.11 M(+0.1%) |
| Nov 2013 | - | $418.00 K(-38.8%) | $2.11 M(+3.9%) |
| Aug 2013 | $2.03 M(+68.9%) | $682.90 K(+36.9%) | $2.03 M(+16.1%) |
| May 2013 | - | $499.00 K(-2.3%) | $1.75 M(+13.5%) |
| Feb 2013 | - | $510.80 K(+50.6%) | $1.54 M(+22.3%) |
| Nov 2012 | - | $339.20 K(-15.3%) | $1.26 M(+4.8%) |
| Aug 2012 | $1.20 M(-5.7%) | $400.70 K(+37.8%) | $1.20 M(+8.7%) |
| May 2012 | - | $290.70 K(+26.6%) | $1.11 M(-5.1%) |
| Feb 2012 | - | $229.70 K(-18.5%) | $1.17 M(-6.1%) |
| Nov 2011 | - | $281.90 K(-7.5%) | $1.24 M(-2.6%) |
| Aug 2011 | $1.28 M(-15.4%) | $304.80 K(-12.9%) | $1.28 M(-16.9%) |
| May 2011 | - | $350.10 K(+14.4%) | $1.54 M(-6.1%) |
| Feb 2011 | - | $305.90 K(-2.9%) | $1.64 M(+6.3%) |
| Nov 2010 | - | $315.10 K(-44.2%) | $1.54 M(+2.0%) |
| Aug 2010 | $1.51 M(+24.7%) | $564.60 K(+25.3%) | $1.51 M(+18.4%) |
| May 2010 | - | $450.70 K(+116.4%) | $1.27 M(+31.7%) |
| Feb 2010 | - | $208.30 K(-26.9%) | $967.90 K(-14.4%) |
| Nov 2009 | - | $285.00 K(-13.8%) | $1.13 M(-8.0%) |
| Aug 2009 | $1.21 M(-19.6%) | $330.50 K(+129.4%) | $1.23 M(-17.4%) |
| May 2009 | - | $144.10 K(-61.2%) | $1.49 M(-13.7%) |
| Feb 2009 | - | $371.50 K(-3.1%) | $1.73 M(+6.4%) |
| Nov 2008 | - | $383.40 K(-35.0%) | $1.62 M(+7.8%) |
| Aug 2008 | $1.50 M(+63.9%) | $589.40 K(+54.7%) | $1.50 M(+9.0%) |
| May 2008 | - | $381.00 K(+42.2%) | $1.38 M(+11.0%) |
| Feb 2008 | - | $268.00 K(+0.8%) | $1.24 M(+9.4%) |
| Nov 2007 | - | $266.00 K(-42.9%) | $1.14 M(+23.7%) |
| Aug 2007 | $918.00 K(+326.8%) | $465.60 K(+91.1%) | $918.00 K(+71.9%) |
| May 2007 | - | $243.70 K(+51.6%) | $534.00 K(+28.0%) |
| Feb 2007 | - | $160.70 K(+234.8%) | $417.20 K(+61.6%) |
| Nov 2006 | - | $48.00 K(-41.2%) | $258.10 K(+20.0%) |
| Aug 2006 | $215.10 K(+380.1%) | $81.60 K(-35.7%) | $215.10 K(+61.1%) |
| May 2006 | - | $126.90 K(+7831.3%) | $133.50 K(+1922.7%) |
| Feb 2006 | - | $1600.00(-68.0%) | $6600.00(+32.0%) |
| Nov 2005 | - | $5000.00 | $5000.00 |
| Aug 2005 | $44.80 K | - | - |
FAQ
- What is Oramed Pharmaceuticals annual SGA?
- What is the all time high annual SGA for Oramed Pharmaceuticals?
- What is Oramed Pharmaceuticals annual SGA year-on-year change?
- What is Oramed Pharmaceuticals quarterly SGA?
- What is the all time high quarterly SGA for Oramed Pharmaceuticals?
- What is Oramed Pharmaceuticals quarterly SGA year-on-year change?
- What is Oramed Pharmaceuticals TTM SGA?
- What is the all time high TTM SGA for Oramed Pharmaceuticals?
- What is Oramed Pharmaceuticals TTM SGA year-on-year change?
What is Oramed Pharmaceuticals annual SGA?
The current annual SGA of ORMP is $8.14 M
What is the all time high annual SGA for Oramed Pharmaceuticals?
Oramed Pharmaceuticals all-time high annual SGA is $15.66 M
What is Oramed Pharmaceuticals annual SGA year-on-year change?
Over the past year, ORMP annual SGA has changed by -$7.52 M (-48.04%)
What is Oramed Pharmaceuticals quarterly SGA?
The current quarterly SGA of ORMP is $847.00 K
What is the all time high quarterly SGA for Oramed Pharmaceuticals?
Oramed Pharmaceuticals all-time high quarterly SGA is $6.08 M
What is Oramed Pharmaceuticals quarterly SGA year-on-year change?
Over the past year, ORMP quarterly SGA has changed by $0.00 (0.00%)
What is Oramed Pharmaceuticals TTM SGA?
The current TTM SGA of ORMP is -$626.81 M
What is the all time high TTM SGA for Oramed Pharmaceuticals?
Oramed Pharmaceuticals all-time high TTM SGA is -$834.00 K
What is Oramed Pharmaceuticals TTM SGA year-on-year change?
Over the past year, ORMP TTM SGA has changed by -$633.25 M (-9842.17%)